Antonio Passaro/X
Apr 11, 2025, 17:22
Antonio Passaro: Discussed the evolving treatment landscape for patients with EGFR-mutant NSCLC at ISCO25
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn:
“It was a real pleasure to be back in Cairo for the ISCO (International Society of Clinical Oncology) annual meeting!
This year, I had the pleasure to discuss the evolving treatment landscape for patients with EGFR-mutant NSCLC—an area that continues to change quickly and challenge us to rethink our clinical approach!
Thanks to the organizers, especially to the Congress Presidents, and friends, Tamer Elnahas, Mohamed Yassin and Walid Arafaat, for hosting such a well-organized and engaging event, that continues to grow year after year.
See you at ISCO26″
More posts featuring Antonio Passaro.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 17:56
Aug 1, 2025, 17:42